2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
15
Prostatic Neoplasms
11
Osteoporosis
6
Neoplasms
4
Melanoma
3
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Cardiovascular Diseases
2
Carcinoma, Non-Small-Cell Lung
2
Wilms Tumor
1
Unspecified Childhood Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Sarcoma, Ewing
1
Regional Osteoporosis as a Result of Chemotherapy
1
Recurrence
1
Primary Ovarian Insufficiency
1
Polycystic Ovary Syndrome
1
Paraganglioma, Extra-Adrenal
1
Pain
1
Ovarian Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Monoclonal Gammopathy of Undetermined Significance
1
Interventions
Lenalidomide
17
Dexamethasone
15
Calcium Dobesilate
8
daratumumab
5
dexamethasone acetate
4
dexamethasone 21-phosphate
4
carfilzomib
4
auricularum
4
Melphalan
4
Leflunomide
3
Curcumin
3
isatuximab
2
iberdomide
2
elotuzumab
2
Peripheral Blood Stem Cell Transplantation
2
PVX-410 vaccine
2
Denosumab
2
Cyclophosphamide
2
Bortezomib
2
siltuximab
1
selinexor
1
sargramostim
1
pomalidomide
1
poly ICLC
1
piperine
1
pembrolizumab
1
ixazomib
1
ibrutinib
1
fludarabine phosphate
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Smoldering Multiple Myeloma
×
Absorptiometry, Photon
×
Clear all
NCT03951220
2025-08-19
LOOMIS
Oxford University Hospitals NHS Trust
Completed
67 enrolled
24 charts